vs

Side-by-side financial comparison of Dexcom (DXCM) and SS&C Technologies Holdings Inc (SSNC). Click either name above to swap in a different company.

SS&C Technologies Holdings Inc is the larger business by last-quarter revenue ($1.6B vs $1.3B, roughly 1.3× Dexcom). Dexcom runs the higher net margin — 21.2% vs 13.7%, a 7.5% gap on every dollar of revenue. On growth, Dexcom posted the faster year-over-year revenue change (21.6% vs 8.8%). Over the past eight quarters, Dexcom's revenue compounded faster (12.0% CAGR vs 6.5%).

Dexcom, Inc. is an American multinational healthcare company that develops, manufactures, produces and distributes a line of continuous glucose monitoring (CGM) systems for diabetes management. It operates internationally with global headquarters and R&D center in San Diego, California, U.S.A. and manufacturing facilities in Mesa, Arizona, U.S.A.; Batu Kawan, Malaysia and Athenry, County Galway, Ireland.

SS&C Technologies Holdings, Inc. is an American multinational holding company headquartered in Windsor, Connecticut, that sells software and software as a service to the financial services industry. The company has offices in the Americas, Europe, Asia, Africa and Australia.

DXCM vs SSNC — Head-to-Head

Bigger by revenue
SSNC
SSNC
1.3× larger
SSNC
$1.6B
$1.3B
DXCM
Growing faster (revenue YoY)
DXCM
DXCM
+12.8% gap
DXCM
21.6%
8.8%
SSNC
Higher net margin
DXCM
DXCM
7.5% more per $
DXCM
21.2%
13.7%
SSNC
Faster 2-yr revenue CAGR
DXCM
DXCM
Annualised
DXCM
12.0%
6.5%
SSNC

Income Statement — Q1 FY2026 vs Q1 FY2026

Metric
DXCM
DXCM
SSNC
SSNC
Revenue
$1.3B
$1.6B
Net Profit
$267.3M
$226.1M
Gross Margin
62.9%
48.7%
Operating Margin
25.6%
24.2%
Net Margin
21.2%
13.7%
Revenue YoY
21.6%
8.8%
Net Profit YoY
153.6%
6.2%
EPS (diluted)
$0.67
$0.91

Green = leading value per metric. Periods may differ when fiscal calendars don't align.

8-Quarter Revenue & Profit Trend

Side-by-side quarterly history. Quarters aligned by calendar period so offset fiscal years line up.

Revenue
DXCM
DXCM
SSNC
SSNC
Q1 26
$1.3B
$1.6B
Q4 25
$1.3B
$1.7B
Q3 25
$1.2B
$1.6B
Q2 25
$1.2B
$1.5B
Q1 25
$1.0B
$1.5B
Q4 24
$1.1B
$1.5B
Q3 24
$994.2M
$1.5B
Q2 24
$1.0B
$1.5B
Net Profit
DXCM
DXCM
SSNC
SSNC
Q1 26
$267.3M
$226.1M
Q4 25
$267.3M
$193.1M
Q3 25
$283.8M
$210.0M
Q2 25
$179.8M
$180.8M
Q1 25
$105.4M
$213.0M
Q4 24
$151.7M
$248.2M
Q3 24
$134.6M
$164.4M
Q2 24
$143.5M
$190.3M
Gross Margin
DXCM
DXCM
SSNC
SSNC
Q1 26
62.9%
48.7%
Q4 25
62.9%
47.8%
Q3 25
60.5%
47.7%
Q2 25
59.5%
48.0%
Q1 25
56.9%
49.3%
Q4 24
58.9%
49.3%
Q3 24
59.7%
48.0%
Q2 24
62.4%
48.1%
Operating Margin
DXCM
DXCM
SSNC
SSNC
Q1 26
25.6%
24.2%
Q4 25
25.6%
22.3%
Q3 25
20.1%
23.3%
Q2 25
18.4%
22.4%
Q1 25
12.9%
23.6%
Q4 24
17.0%
23.4%
Q3 24
15.3%
22.2%
Q2 24
15.7%
22.6%
Net Margin
DXCM
DXCM
SSNC
SSNC
Q1 26
21.2%
13.7%
Q4 25
21.2%
11.7%
Q3 25
23.5%
13.4%
Q2 25
15.5%
11.8%
Q1 25
10.2%
14.1%
Q4 24
13.6%
16.2%
Q3 24
13.5%
11.2%
Q2 24
14.3%
13.1%
EPS (diluted)
DXCM
DXCM
SSNC
SSNC
Q1 26
$0.67
$0.91
Q4 25
$0.67
$0.76
Q3 25
$0.70
$0.83
Q2 25
$0.45
$0.72
Q1 25
$0.27
$0.84
Q4 24
$0.37
$0.98
Q3 24
$0.34
$0.65
Q2 24
$0.35
$0.75

Balance Sheet & Financial Strength

Snapshot of each company's liquidity, leverage and book value from the latest quarter.

Metric
DXCM
DXCM
SSNC
SSNC
Cash + ST InvestmentsLiquidity on hand
$917.7M
$420.9M
Total DebtLower is stronger
$7.4B
Stockholders' EquityBook value
$2.7B
$6.9B
Total Assets
$6.3B
$20.3B
Debt / EquityLower = less leverage
1.08×

8-quarter trend — quarters aligned by calendar period.

Cash + ST Investments
DXCM
DXCM
SSNC
SSNC
Q1 26
$917.7M
$420.9M
Q4 25
$917.7M
$462.1M
Q3 25
$1.8B
$388.3M
Q2 25
$1.2B
$480.3M
Q1 25
$904.9M
$515.0M
Q4 24
$606.1M
$567.1M
Q3 24
$621.2M
$694.7M
Q2 24
$939.2M
$462.7M
Total Debt
DXCM
DXCM
SSNC
SSNC
Q1 26
$7.4B
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24
Stockholders' Equity
DXCM
DXCM
SSNC
SSNC
Q1 26
$2.7B
$6.9B
Q4 25
$2.7B
$6.9B
Q3 25
$2.7B
$6.9B
Q2 25
$2.6B
$6.9B
Q1 25
$2.3B
$6.8B
Q4 24
$2.1B
$6.5B
Q3 24
$2.0B
$6.8B
Q2 24
$2.4B
$6.4B
Total Assets
DXCM
DXCM
SSNC
SSNC
Q1 26
$6.3B
$20.3B
Q4 25
$6.3B
$20.7B
Q3 25
$7.5B
$19.5B
Q2 25
$7.3B
$19.0B
Q1 25
$6.8B
$20.4B
Q4 24
$6.5B
$19.0B
Q3 24
$6.4B
$18.4B
Q2 24
$6.8B
$16.9B
Debt / Equity
DXCM
DXCM
SSNC
SSNC
Q1 26
1.08×
Q4 25
Q3 25
Q2 25
Q1 25
Q4 24
Q3 24
Q2 24

Cash Flow & Capital Efficiency

How much cash each business actually produces after reinvestment. Cash flow is harder to manipulate than net income.

Metric
DXCM
DXCM
SSNC
SSNC
Operating Cash FlowLast quarter
$299.7M
Free Cash FlowOCF − Capex
FCF MarginFCF / Revenue
Capex IntensityCapex / Revenue
0.0%
Cash ConversionOCF / Net Profit
1.33×
TTM Free Cash FlowTrailing 4 quarters

8-quarter trend — quarters aligned by calendar period.

Operating Cash Flow
DXCM
DXCM
SSNC
SSNC
Q1 26
$299.7M
Q4 25
$294.0M
$643.5M
Q3 25
$659.9M
$456.2M
Q2 25
$303.0M
$372.9M
Q1 25
$183.8M
$272.2M
Q4 24
$301.4M
$486.6M
Q3 24
$199.5M
$336.6M
Q2 24
$279.4M
$384.9M
Free Cash Flow
DXCM
DXCM
SSNC
SSNC
Q1 26
Q4 25
$192.1M
$633.0M
Q3 25
$579.4M
$421.5M
Q2 25
$208.9M
$350.0M
Q1 25
$96.8M
$259.5M
Q4 24
$176.8M
$466.9M
Q3 24
$88.3M
$310.7M
Q2 24
$213.3M
$374.9M
FCF Margin
DXCM
DXCM
SSNC
SSNC
Q1 26
Q4 25
15.3%
38.3%
Q3 25
47.9%
26.9%
Q2 25
18.1%
22.8%
Q1 25
9.3%
17.1%
Q4 24
15.9%
30.5%
Q3 24
8.9%
21.2%
Q2 24
21.2%
25.8%
Capex Intensity
DXCM
DXCM
SSNC
SSNC
Q1 26
0.0%
Q4 25
8.1%
0.6%
Q3 25
6.7%
2.2%
Q2 25
8.1%
1.5%
Q1 25
8.4%
0.8%
Q4 24
11.2%
1.3%
Q3 24
11.2%
1.8%
Q2 24
6.6%
0.7%
Cash Conversion
DXCM
DXCM
SSNC
SSNC
Q1 26
1.33×
Q4 25
1.10×
3.33×
Q3 25
2.33×
2.17×
Q2 25
1.69×
2.06×
Q1 25
1.74×
1.28×
Q4 24
1.99×
1.96×
Q3 24
1.48×
2.05×
Q2 24
1.95×
2.02×

Financial Flow Comparison

Revenue → gross profit → operating profit → net profit for each company.

Revenue Breakdown by Segment

DXCM
DXCM

Segment breakdown not available.

SSNC
SSNC

Technology-enabled services$1.4B85%
License, maintenance and related$239.8M15%

Related Comparisons